112 related articles for article (PubMed ID: 6841162)
1. Detection of HLA antigens on lymphoblastoid and epithelial cell lines and cross-reactivity of HLA-Cw5 and HLA-Cw8.
O'Toole CM; Lewis CM; Wolf E
Hum Immunol; 1983 Mar; 6(3):119-31. PubMed ID: 6841162
[TBL] [Abstract][Full Text] [Related]
2. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity.
O'Toole CM; Tiptaft RC; Stevens A
Int J Cancer; 1982 Apr; 29(4):391-5. PubMed ID: 7085129
[TBL] [Abstract][Full Text] [Related]
3. HLA-B*15:33, a rare allele whose product reacts as an HLA-B62 and -Cw5/Cw8 specificity.
Street J; Climer T; Johnson J; Darke C
Int J Immunogenet; 2012 Feb; 39(1):79-81. PubMed ID: 22010883
[TBL] [Abstract][Full Text] [Related]
4. The HLA--B14 cross-reactive group.
Darke C
Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
[TBL] [Abstract][Full Text] [Related]
5. HLA-B14 subtyping by semi-nested PCR-SSP and haplotype distribution in a Spanish population.
Santos S; Balas A; Lillo R; Garcia-Sanchez F; Merino JL; Vicario JL
Tissue Antigens; 1997 Dec; 50(6):671-4. PubMed ID: 9458126
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity against HLA-A, HLA-B and HLA-DR specificities.
Akiyama N; Ohsawa N; Kano K
Int Arch Allergy Appl Immunol; 1984; 74(3):286-8. PubMed ID: 6327536
[TBL] [Abstract][Full Text] [Related]
7. Improved detection of HLA-Cw5 and Cw7 by two colour fluorescence technique.
Nieman H; Parlevliet J; Schreuder I
Tissue Antigens; 1983 Nov; 22(5):372-8. PubMed ID: 6362070
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
9. Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.
Castelli C; Tarsini P; Mazzocchi A; Rini F; Rivoltini L; Ravagnani F; Gallino F; Belli F; Parmiani G
J Immunol; 1999 Feb; 162(3):1739-48. PubMed ID: 9973437
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
Cresswell P; Ayres JL
Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
[TBL] [Abstract][Full Text] [Related]
11. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.
Schäfer K; Albert ED; Rodt H; Thierfelder S
Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938
[TBL] [Abstract][Full Text] [Related]
12. A F(ab')2 fragment blocking study of the HLA-B14 antigen.
Darke C
Tissue Antigens; 1985 Apr; 25(4):177-86. PubMed ID: 2409633
[TBL] [Abstract][Full Text] [Related]
13. Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. Implications for the control of expression and immunogenicity of HLA-C antigens.
Tibensky D; DeMars R; Holowachuk EW; Delovitch TL
J Immunol; 1989 Jul; 143(1):348-55. PubMed ID: 2732471
[TBL] [Abstract][Full Text] [Related]
14. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
Schneider MU; Troye M; Paulie S; Perlmann P
Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera.
Corley RB; Dawson JR; Amos DB
Eur J Immunol; 1976 Apr; 6(4):235-40. PubMed ID: 186270
[TBL] [Abstract][Full Text] [Related]
16. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
Darke C
Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
[No Abstract] [Full Text] [Related]
17. Suppression of lymphoblastoid cell line proliferation by antisera to HLA-DR and other HLA antigens.
Gatti RA; Cousineau M; Naeim F; Leibold W
Tissue Antigens; 1979 Sep; 14(3):213-22. PubMed ID: 316587
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
Falk CS; Steinle A; Schendel DJ
J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
[TBL] [Abstract][Full Text] [Related]
20. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
Darke C
Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
